Perioperative screening for obstructive sleep apnoea and treatment outcomes: where are the data?

Obstructive sleep apnoea (OSA) is common illness found worldwide, with a reported prevalence ranging from 9% to 24% among the general population [1]. In the USA, approximately 92% of women and 82% of men with moderate-to-severe OSA remain undiagnosed [2]. OSA carries several short- and long-term health consequences. These may range from perioperative complications to the risk of having uncontrolled hypertension, stroke, coronary artery disease and dysrhythmias, to name a few [3–8].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Sleep medicine Editorials Source Type: research